Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: Biochemical evidence for the cancellous bone-remodeling compartment

Journal of Bone and Mineral Research

Volumn 17, Issue 7, 2002, Pages 1171-1179

  Price, Paul A ^a   Caputo, Jeffrey M ^a   Williamson, Matthew K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancellous bone remodeling compartment; Fetuin; Matrix Gla protein; Serum mineral complex

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; CALCIUM PHOSPHATE; ETIDRONIC ACID; FETUIN; OSTEOCALCIN; OSTEOPROTEGERIN; PHOSPHATE; PROTEIN; ALPHA FETOPROTEIN; CALCIUM BINDING PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN; TNFRSF11B PROTEIN, HUMAN; TNFRSF11B PROTEIN, RAT; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BONE LEVEL; BONE MINERALIZATION; BONE REMODELING; CALCIUM BONE LEVEL; CANCELLOUS BONE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PREDICTION; PROTEIN BLOOD LEVEL; RAT; THEORETICAL MODEL; ANIMAL; BLOOD; BONE; DISEASE MODEL; FEEDING BEHAVIOR; HUMAN; INJECTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ALENDRONATE; ALPHA-FETOPROTEINS; ANIMALS; BONE AND BONES; BONE REMODELING; BONE RESORPTION; CALCITONIN; CALCIUM; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ETIDRONIC ACID; EXTRACELLULAR MATRIX PROTEINS; FEEDING BEHAVIOR; GLYCOPROTEINS; HUMANS; INJECTIONS; MALE; OSTEOPROTEGERIN; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS;

EID: 0035991230     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.7.1171     Document Type: Article

References (31)

1. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix Gla protein in the serum of etidronate-treated rats
2. The serum protein alpha 2-HS Glycoprotein/Fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells
3. Cloning and targeted deletion of the mouse fetuin gene
4. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein
5. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves
6. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome
7. Warfarin induced artery calcification is accelerated by growth and by vitamin D
8. Effect of Ethane-l-hydroxy-l,l-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats
9. Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet
10. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption
11. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
12. Developmental appearance of matrix Gla protein during calcification in the rat
13. Microdetermination of phosphorus
14. 3
15. Osteoprotegerin mitigates tail suspension-induced osteopenia
16. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers
17. On the rat model of human osteopenias and osteoporoses
18. The bone remodeling compartment: A circulatory function for bone lining cells
19. Medial calcification (whitlockite) in the aorta
20. Matrix Gla protein specifically inhibits calcification of human aortic elastin in vitro
21. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women
22. Calcification of the aorta and osteoporosis: A roentgenographic study
23. Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: Links between osteoporosis and cardiovascular disease?
24. Osteroporosis and calcification of the aorta
25. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population based study
26. Osteoporosis and atherosclerosis in chronic renal failure
27. Bone changes and carotid atherosclerosis in postmenopausal women
28. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
29. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
30. The bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those which inhibit bone resorption
31. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D